Synthesis of heterocycles containing chalcogens by C-H functionalization: a green approach

Tese (doutorado) - Universidade Federal de Santa Catarina, Centro de Ciências Físicas e Matemáticas, Programa de Pós-Graduação em Química, Florianópolis, 2014.No presente trabalho desenvolveram-se novas metodologias eficientes, econômicas e ambientalmente adequadas para a síntese de oxadiazóis e benzotiazóis contendo uma porção organocalcogênio. Primeiramente, desenvolvemos a síntese de oxadiazóis selenados e tiolados através da funcionalização de ligação Csp2-H promovida por K2CO3, em um meio reacional livre de metais de transição. Em uma primeira etapa foram preparados oxadiazóis selenados com potencial para aplicações biológicas. Sob condições suaves, a reação ocorreu de maneira eficiente na presença de um equivalente do correspondente oxadiazol I, um equivalente de base (K2CO3), 0,5 equivalentes do correspondente dicalcogeneto de organoíla II, na presença de ar atmosférico. Através dessa metodologia, uma série de oxadiazóis calcogenados III na posição 5 do heterociclo foram obtidos em rendimentos que variaram de bons a excelentes. Adicionalmente, explorou-se a reatividade dos oxadiazóis selenados 3 em reações de troca calcogênio-lítio. Os intermediários oxadiazóis litiado assim obtidos foram capturados, in situ, com diferentes eletrófilos. É importante salientar, também que essa reação ocorreu de forma eficiente quando se aumentou sua escala para 10 mmol.Em uma segunda etapa desenvolvemos um novo método para a incorporação de calcogênios em benzotiazóis via reação de calcogenação direta da ligação C-H. Realizou-se a síntese de 2-organocalcogeno-1,3- benzotiazóis V através da calcogenação direta entre 1,3-benzotiazóis IV e dicalcogenetos de organoíla II catalizada por Fe3O4 nanopartículado. Esta metodologia permitiu a obtenção dos respectivos produtos calcogenolados V, em rendimentos que variaram de moderados a excelentes. Realizou-se, também, com sucesso, a reciclagem do catalisador em 4 ciclos sem um decréscimo acentuado no rendimento.Abstract : In the present work, we developed efficient, economical and greener procedures for to the synthesis of chalcogenated oxadiazoles and benzothiazoles. In the first part, we developed a K2CO3-promoted procedure for the synthesis of selenated and thiolated oxadiazoles 3 through Csp2-H bond functionalization, under transition metal-free conditions. We prepared for the first time selenated oxadiazoles, compounds with potential for biological applications. Under mild conditions, the reaction worked well in the presence of 1equiv. of oxadiazole I, a half equiv. of diorganyl dichalcogenides II, 1 equiv. of base (K2CO3), without the exclusion of air and moisture, affording a wide range of chalcogenated oxadiazoles III at the C5 position in good to excellent yields. The various substituents with different electronic effects and steric effects tolerated the optimized reaction conditions. Furthermore, selenated oxadiazole was explored for selenium-lithium exchange reaction and lithium-intermediate was trapped by different electrophiles. We were also successful in scaling up the reaction in up to 10 mmol. Subsequently, we developed a new method of incorporation of organoyl chalcogenides in benzothiazoles via direct chalcogenation of C-H bond. In this work, we report the synthesis of 2-organochalcogeno-1,3-benzothiazoles V via direct chalcogenation reactions between 1,3-benzothiazoles IV and diorganyl dichalcogenides II catalyzed by Fe3O4 nano particle. This methodology allowed us to obtain 2-chalcogen-1,3-benzothiazoles in moderate to excellent yields, as well as recycling successful the catalyst in up to 4 cycles without any major decrease in the yield

2-[(1R*,4R*)-1,4-Dihy­droxy­cyclo­hex­yl]acetic acid

The title compound, C8H14O4, is an isolation product of the aerial parts of Senecio desfontanei. The acetic acid group is oriented at a dihedral angle of 48.03 (9)° with respect to the basal plane of the cyclo­hexane-1,4-diol chair. An intra­molecular O—H⋯O hydrogen bond generates an S(6) ring with an envelope conformation. In the crystal, mol­ecules are linked by O—H⋯O hydrogen bonds, resulting in R 3 3(20) ring motifs and C(2) O—H⋯O—H⋯O—H⋯ chains. Overall, a three-dimensional polymeric network arises. A C—H⋯O contact is also present

A Subjective Study on the Effects of Dynamic Virtual Chemistry Laboratory in a Secondary School Education

Virtual chemistry laboratories (VCLs) are the alternative solutions of the physical laboratories, where students can virtually conduct their experiments with a lower cost, and in an efficient and safer way. Considering the importance of technology-enhanced learning and that of the experimental study, several VCLs have been proposed. However, the existing VCLs are static and only provide the simulation of pre-defined experiments, procedures, or safety procedures and cannot be adapted according to the students’ level or new experimental tasks. In this paper, we proposed a dynamic virtual chemistry lab (DVCL) where instructors or experts are allowed to add a new chemical experiment by adding its apparatus, chemicals, glassware, and mechanism or add something new to its properties. We conducted a subjective study with field experts to investigate the effect of proposed DVCL in secondary school chemistry education. During evaluation, twenty-seven field experts were participated and evaluated the proposed DVCL with system usability scale (SUS)-questionnaire and by a simple questionnaire. The results showed that the proposed DVCL is very helpful for students’ performance and mental modeling and also for effortlessly uplifting their knowledge for hands-on experiments

Synthesis of Selenium-Quinone Hybrid Compounds with Potential Antitumor Activity via Rh-Catalyzed C-H Bond Activation and Click Reactions

In continuation of our quest for new redox-modulating catalytic antitumor molecules, selenium-containing quinone-based 1,2,3-triazoles were synthesized using rhodium-catalyzed C-H bond activation and click reactions. All compounds were evaluated against five types of cancer cell lines: HL-60 (human promyelocytic leukemia cells), HCT-116 (human colon carcinoma cells), SF295 (human glioblastoma cells), NCIH-460 (human lung cells) and PC3 (human prostate cancer cells). Some compounds showed good activity with IC50 values below 1 µM. The cytotoxic potential of the naphthoquinoidal derivatives was also evaluated in non-tumor cells, exemplified by L929 cells. Overall, these compounds represent promising new lead derivatives and stand for a new class of chalcogenium-containing derivatives with potential antitumor activity

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Impact of Land-use Change on Agricultural Production & Accuracy Assessment through Confusion Matrix

Land modification and its allied resources have progressively become a severe problem presently pulling the worldwide attention and now it rests at the central point of the conservation of the environment and sustainability. The present research aimed to examine the land-use changes and their impact on agricultural production using remote sensing and GIS techniques over the study area that comprised of Tehsil Shorkot, District Jhang, Punjab, Pakistan. Images were pre-processed by using the Arc GIS and ERDAS Imagine 15 software for stacking of the layers, sub-setting, and mosaicking of the satellite bands. After the pre-processing of the images, supervised image classification scheme was applied by employing a maximum likelihood algorithm to recognize the land-use changes which have been observed in the area under study. The area under water was occupied 9.6 km2 in 2010 that increased to 21.04 km2 in 2015 and decreased to 19.4 km2in 2020. Built-up land was 16.6 km2 in 2010 that increased to 19.4 km2 in 2015 and 26.8 km2 in 2020. The total area under vegetation was computed as 513.2 km2 in 2010 that increased to 601.6km2 in 2015 and further increased to 717.7 km2in 2020. Forest land use showed decreasing trend as the covered area in 2010 was occupied 90.8 km2 that decreased to 86.7 km2 in 2015 and further decreased to 61.84 km2 in 2020. In 2010, barren land use was occupied 528.54 km2 that considerably decreased to 429.64 km2 in 2015 further decreased to 333.1 km2 in 2020. Barren land drastically decreased into watered, built-up, and vegetation land uses. The findings of this study will be helpful for the future conservation of various land-use types, urban and regional planning, and an increase in agricultural production of various crops in the study area. Full Tex